Sarepta price target raised to $157 from $151 at RBC Capital

RBC Capital raised the firm’s price target on Sarepta to $157 from $151 and keeps an Outperform rating on the shares. The company’s Q4 results were “relatively uneventful” after its earlier pre-announcement as its management continues to be very confident in the Elevidys regulatory path and seeks a broad label, though regulatory feedback sounds limited so far, the analyst tells investors in a research note.